The online version of this article (doi:10.1186/1477-7819-10-117) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
RG collected and analysed the data and wrote the manuscript. RB refined the study design and corrected the manuscript. GF conceived the study, created the study design, corrected and submitted the manuscript. All authors have read and approved the final manuscript.
Cutaneous squamous cell carcinoma (cSCC) comprises 20% of all skin cancer of the head and neck. A minority will metastasize to regional parotid lymph nodes. This study evaluates the St Vincent’s Hospital, Sydney experience between 1996 and 2006.
A retrospective review was performed of patients who were evaluated in our multidisciplinary head and neck clinic with metastatic cSCC to parotid, and all treatment and pathologic details were reviewed. Statistical analysis, including univariate and multivariate analyses, were performed using Cox proportional hazards regression mode, overall and disease-specific survival were estimated by the Kaplan-Meier method.
Sixty-seven patients were identified. Some 90 % were male, and with a mean age of 72.8 years. One died on the first postoperative day. The remaining 66 patients received radiotherapy. For these 66 patients, the two-year and five-year overall survival rate was 0.83 and 0.72, respectively. The two-year and five-year disease-free survival rate was 0.91 and 0.83 respectively. Overall survival was only significantly correlated to the extent of parotidectomy (superficial versus total; P = 0.0256). Margin status was available in 59 patients. The only parameter that significantly correlated with disease-free survival was margin status (close/negative versus positive P = 0.0348). Other parameters of immune suppression, perineural invasion, extra capsular extension, degree of tumour differentiation, number of positive nodes, extent of neck dissection and radiotherapy dosage delivered did not confer prognostic significance.
This study confirmed the association of adverse prognostic implication of positive margins on disease-free survival. Immune compromise was not a significant factor in this small group. Further studies are warranted in this population.
Additional file 1: A table showing overall survival. (DOC 306 KB)12957_2012_1020_MOESM1_ESM.doc
Additional file 2: A table showing disease-specific survival. (DOC 109 KB)12957_2012_1020_MOESM2_ESM.doc
Authors’ original file for figure 112957_2012_1020_MOESM3_ESM.pdf
Authors’ original file for figure 212957_2012_1020_MOESM4_ESM.pdf
Authors’ original file for figure 312957_2012_1020_MOESM5_ESM.pdf
Authors’ original file for figure 412957_2012_1020_MOESM6_ESM.pdf
Authors’ original file for figure 512957_2012_1020_MOESM7_ESM.doc
Authors’ original file for figure 612957_2012_1020_MOESM8_ESM.doc
Authors’ original file for figure 712957_2012_1020_MOESM9_ESM.doc
Authors’ original file for figure 812957_2012_1020_MOESM10_ESM.doc
Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG: Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006, 184: 6-10. PubMed
Australian Institute of Health and Welfare (AIHW)& Australian cancer incidence and mortality workbooks (ACIM). 2010, Canberra: AIHW, Retrieved from [ www.aihw.gov.au/cancer/data/acim_books/index.cfm] on 13 October 2011
Robbins KT, Shaha AR, Medina JE, Califano JA, Wolf GT, Ferlito A, Som PM, Day TA, Committee for Neck Dissection Classification, American Head and Neck Society: Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008, 134: 536-538. 10.1001/archotol.134.5.536. CrossRefPubMed
Ch’ng S, Maitra A, Lea R, Brasch H, Tan ST: Parotid metastasis - An independent prognostic factor for head and neck cutaneous squamous cell carcinoma. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2006, 59: 1288-129. 10.1016/j.bjps.2006.03.043. CrossRef
Chua MS, Veness MJ, Morgan G, Shakespeare T, Hehir A, Gebski V, Cakir B, Tiver KW: Parotid lymph-node metastases from cutaneous squamous-cell carcinomas: treatment outcome and prognostic factors following surgery and adjuvant radiotherapy. Australas Radiol. 2002, 46: 174-179. 10.1046/j.1440-1673.2001.01030.x. CrossRefPubMed
Palme CE, O’Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ: Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Archives of otolaryngology- head & neck surgery. 2003, 129: 750-753. 10.1001/archotol.129.7.750. CrossRef
Veness MJ, Morgan GJ, Palme CE, Gebski V: Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005, 115: 870-875. 10.1097/01.MLG.0000158349.64337.ED. CrossRefPubMed
O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS: Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001, 73: 744-748. CrossRef
- Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome
Robin Yeong Hong Goh
Gerald B Fogarty
- BioMed Central
Neu im Fachgebiet Chirurgie
e.Med Kampagnen-Visual, Mail Icon II